Home - Resources -Topicbiosimilars

November 22, 2023
National Alliance In The News

Expert Discusses Biosimiliars Influencing Pricing of Biologic Drugs

Pharmacy Times

September 18, 2023
National Alliance In The News

Save billions or stick with Humira? Drug brokers steer Americans to the costly choice

Los Angeles Times

June 28, 2023
National Alliance In The News

The Age of Adalimumab Is Upon Us: How Stakeholders Can Prepare

Center for Biosimilars

March 2, 2023
Playbook

Employer Playbook on Biosimilars

Employer and other healthcare purchasers grapple with how best to integrate biologics into health and pharmacy benefit plans. The National Alliance has developed this playbook to provide clear information to […]

March 22, 2022
Action Brief

Improving Drug Management Employer Biosimilar Strategies

This Action Brief helps employers understand and overcome obstacles to biosimilar uptake. Case studies from leading employers illustrate how they are saving millions by transitioning patients to safe and effective […]

February 21, 2022
Playbook

Improving Drug Management Employer Strategies on Biosimilars

Biosimilars have garnered significant press over the past few years, with a primary focus onsavings for employers. This savings is significant, as increased use of biosimilars will allow fora more […]

Reducing Medical Errors in the Hospital:

Employer Insights to Consolidated Appropriations Act Attestation

Pulse of the Purchaser 2023 Survey Results

Addressing Obesity through Holistic Design for Affordability and Sustainability

Beyond the Pulse – Pulse of the Purchaser Webinar Series

Lower Costs, More Transparency Act

Employer Strategies in Health Equity: Building and Sustaining a Culture of Inclusion

Evaluating People-Centered Design Practices

Going Deep on Mental Health Parity Webinar Share

Accelerating Health Equity Across the Supply Chain Share